Preconditioning human cardiomyocytes and endothelial cells  by Shirai, Toshizumi et al.
PRECONDITIONING HUMAN CARDIOMYOCYTES AND ENDOTHELIAL CELLS
Toshizumi Shirai, MD, PhD
Vivek Rao, MD
Richard D. Weisel, MD
John S. Ikonomidis, MD, PhD
Ren-Ke Li, MD, PhD
Laura C. Tumiati, BSc
Frank Merante, PhD
Donald A. G. Mickle, MD
Background: The effects of simulated “ischemia” and “reperfusion” were
evaluated in cell cultures of human ventricular cardiomyocytes and human
saphenous vein endothelial cells. Methods: Myocyte and endothelial cell
cultures were exposed to a low volume (1.5 ml) of either hypoxic (oxygen
tension 5 16 mm Hg) or anoxic (oxygen tension 5 0 mm Hg) phosphate-
buffered saline solution for 90 minutes (“ischemia”) followed by 30 minutes
of simulated “reperfusion.” Cell injury was evaluated by trypan blue
exclusion. Next, the effects of a preconditioning stimulus were evaluated by
a brief (10 minute) exposure to hypoxic or anoxic ischemia and 10 minutes
of reperfusion before prolonged (90 minutes) anoxic ischemia. Finally, the
effects of anoxic preconditioning on intracellular lactate accumulation and
extracellular lactate and acid release were assessed. Results: “Ischemia”
and “reperfusion” resulted in greater injury to endothelial cells than to
cardiomyocytes. In both cell types, anoxic ischemia resulted in greater
injury than hypoxic ischemia. Preconditioning reduced cell injury in
myocytes but not in endothelial cells. Endothelial cells produced more
lactate than cardiomyocytes under normoxic conditions. Ischemia in-
creased lactate accumulation and release in cardiomyocytes but not endo-
thelial cells. Preconditioning reduced lactate accumulation and release in
cardiomyocytes but not endothelial cells. Conclusions: Endothelial cells
were more susceptible to the same period of simulated ischemia than
cardiomyocytes. Preconditioning protected cardiomyocytes but not endo-
thelial cells from a subsequent prolonged period of ischemia and reperfu-
sion. (J Thorac Cardiovasc Surg 1998;115:210-9)
The response of the coronary endothelium toischemia and reperfusion remains controversial.
Morphologic studies1 have suggested minor changes
to the endothelium despite significant ischemic
changes in myocytes after a coronary occlusion.
However, the endothelium is metabolically active
and produces endothelin,2 nitric oxide,3 and adeno-
sine.4 The secretion of these and other substances
controls coronary perfusion and may alter myocardial
contractility.5 Ischemic injury to the endothelium may
alter its metabolic activity without substantially alter-
ing structure. Several studies have implicated endothe-
lial dysfunction in the pathogenesis of myocardial
infarction.6-9 Therefore protection against ischemic
injury should be directed toward both myocytes and
endothelial cells.
Ischemic preconditioning is a powerful endoge-
nous mechanism of cardioprotection.10 Precondi-
tioning has been shown to reduce infarct size by at
least 80%. However, the effects of ischemic precon-
ditioning on endothelial cells remains controversial.
Recent studies suggest that preconditioning pre-
serves endothelium-dependent regulation of coro-
nary blood flow.11, 12 Most studies have used whole
heart preparations. The differential effects of isch-
emia and the potential benefits of preconditioning
have been incompletely investigated in isolated cell
preparations. In addition, studies evaluating a pre-
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conditioning response in human beings did not
distinguish between the effects on endothelial cells
and cardiomyocytes.13, 14
We developed a model of simulated “ischemia” in
monolayers of cultured human cells.15 Cultured cells
have distinct advantages and definite disadvantages.
Cell cultures permit a comparison of isolated cell
types to a standard ischemic insult. Therefore the
effects of preconditioning on isolated cell cultures
permit a comparison independent of the influences
of other cell types or organ systems. However, the
response in cell cultures may not predict the re-
sponse of whole organs to ischemia. In addition,
culturing cardiomyocytes and endothelial cells re-
sults in cellular dedifferentiation with a loss of some
cell functions. We have documented the phenotypic
changes that occur with passaging in our human
ventricular cardiomyocyte cultures.16 Although en-
dothelial cells from different vascular beds display
different properties in vivo, we have found that
cultured endothelial cells partially dedifferentiate to
a common cell line.17 Despite these limitations, we
believe that our “ischemic” model provides a unique
opportunity to investigate the effects of precondi-
tioning and to explain the differential response of
human cardiomyocytes and endothelial cells to sim-
ulated “ischemia” and “reperfusion.” In addition,
this model enables the evaluation of pharmacologic
agents intended to mimic the preconditioning re-
sponse. Agents that have beneficial effects on both
cardiomyocytes and endothelial cells may be ideal
additives to cardioplegic formulations.
Materials and methods
Human ventricular cardiomyocyte culture. Cultures of
human ventricular cardiomyocytes were established as
previously described.16, 17 In brief, 20 mg biopsy speci-
mens were obtained from the right ventricle of patients
undergoing corrective repair of tetralogy of Fallot. The
myocardial biopsy specimens were washed in phosphate-
buffered saline solution (PBS) without calcium. After
removal of connective tissue, the myocytes were separated
with the use of enzymatic digestion with a mixture of 0.2%
trypsin (Difco Laboratories, Detroit, Mich.) and 0.1%
collagenase (Worthington Biochemical Corp., Freehold,
N.J.). The isolated cells were cultured at 37° C in 5%
carbon dioxide and 95% air in Iscove’s modified Dulbec-
co’s medium (Gibco Laboratories, Grand Island, N.Y.)
containing 10% fetal bovine serum, 100 U/ml penicillin,
100 mg/ml streptomycin, and 0.1 mmol/L b-mercaptoetha-
nol. Purification was achieved by means of the dilution
cloning technique.16 All cells on the plate were allowed to
divide and at 7 days cardiomyocyte, fibroblast, and endo-
thelial colonies formed. Single cardiomyocyte colonies
were then transferred by means of a Pasteur pipette to
Fig. 1. Experimental protocol: All groups were stabilized in normoxic (PO2 5 150 mm Hg), phosphate-
buffered saline (PBS) for 30 minutes before “ischemia” was simulated with a low volume (1.5 ml) of
deoxygenated (PO2 5 0 or 16 mm Hg) PBS, and “reperfusion” was simulated with 15 ml of normoxic PBS.
Stab, Stabilization in normoxic PBS for 30 minutes; I, 90 minutes of simulated “ischemia”; IR, “ischemia”
plus 30 minutes of “reperfusion”; PC, preconditioning with 10 minutes of “ischemia” and 10 minutes of
“reperfusion”; PI, preconditioning plus 90 minutes of “ischemia”; PIR, preconditioning, “ischemia” and 30
minutes of “reperfusion.”
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another culture dish. Cell cultures were inspected daily,
and any contaminated culture dishes were discarded.
Culture purity greater than 95% was demonstrated after
the third cell passage with fluorescent monoclonal anti-
body staining for human ventricular myosin heavy chain
(Rougier Bio-Tech Ltd., Montreal, Quebec). Cells pas-
saged four to seven times with a time from primary culture
of less than 60 days were used for this study.
Human endothelial cell culture. The technique used to
isolate and culture human saphenous vein endothelial
cells has been previously reported.17 In brief, saphenous
vein segments were obtained from patients undergoing
aorta-coronary bypass operations and washed with PBS to
remove blood. After removal of connective tissue, the vein
was incubated in an enzymatic solution (0.2% trypsin and
0.1% collagenase in PBS without calcium). Endothelial
cells were isolated by gently washing the inside of the vein
segment with culture medium (medium 199; Gibco) three
to five times. The isolated cells were cultured at 37° C in
5% carbon dioxide and 95% air in medium 199 containing
20% fetal bovine serum, 100 U/ml penicillin, and 100
mg/ml streptomycin. Endothelial cells were distinguished
from fibroblasts and smooth muscle cells by morphologic
criteria. The cell culture plates were inspected daily, and
any contaminated plates were discarded. Endothelial cell
purity was greater than 95% in all plates used for these
studies and was confirmed by immunofluorescent staining
with a monoclonal antibody against factor VIII antigen.
Endothelial cells passaged four to seven times and aged
less than 60 days from the time of primary culture were
used for this study.
Experimental protocols. The cells were studied in PBS
with magnesium, calcium, and glucose (MgCl2, 0.49
mmol/L; CaCl2, 0.69 mmol/L; glucose, 3 mmol/L). Our in
vitro technique to simulate “ischemia” and “reperfusion”
has been previously described in detail.15 After 30 minutes
of stabilization in 15 ml of normoxic (oxygen tension [PO2]
5 150 mm Hg) PBS, “ischemia” was simulated by placing
the cells into a sealed acrylic plastic chamber flushed with
100% nitrogen and exposing the cells to a low volume (1.5
ml) of deoxygenated PBS for 90 minutes. “Reperfusion”
was accomplished by exposure to 15 ml of normoxic PBS
for 30 minutes. A small sample of deoxygenated PBS (2
ml) was placed into a center dish in the chamber to
monitor temperature and to confirm the absence of
oxygen at the end of the ischemic period. The tempera-
ture was maintained at 37° C throughout the experiment.
Fig. 1 summarizes the experimental protocols. Cells
were assessed after 30 minutes of stabilization, 90 minutes
of prolonged “ischemia” (I), and 90 minutes of prolonged
“ischemia” followed by 30 minutes of “reperfusion” (IR).
Two different levels of deoxygenated PBS were used:
anoxic (PO2 5 0 mm Hg) and hypoxic (PO2 5 16 mm Hg).
The cellular response to ischemic preconditioning was
examined by the following protocols: 10 minutes of brief
“ischemia” followed by 10 minutes of “reperfusion” (PC:
preconditioning), PC followed by 90 minutes of “isch-
emia” (PI), and PI followed by 30 minutes of reperfusion
Fig. 2. Cell injury after ischemia and reperfusion. Left, Anoxic (PO2 5 0 mm Hg) “ischemia.” Cell injury
(percent trypan blue uptake) was greater after “ischemia” in both cardiomyocytes and endothelial cells
(p , 0.001). Injury increased after reperfusion with cardiomyocytes (p , 0.05) but not with endothelial
cells. Cell injury was greater in endothelial cells than cardiomyocytes (p , 0.001). Right, Hypoxic (PO2 5
16 mm Hg) “ischemia.” Cell injury was less after hypoxia than anoxic ischemia and reperfusion in both
cardiomyocytes and endothelial cells (p , 0.0001). Reperfusion injury after hypoxia was found in
cardiomyocytes but not endothelial cells. Data are presented as mean 6 standard error of the mean with
eight plates per group. Abbreviations as detailed in Fig. 1. *p , 0.05 versus Stab; 1p , 0.05 versus
cardiomyocytes; #p , 0.05 versus I; xp , 0.05 versus anoxia.
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(PIR). An anoxic (PO2 5 0 mm Hg) stimulus was used to
precondition against anoxic “ischemia,” whereas a hypoxic
(PO2 5 16 mm Hg) stimulus was used to precondition
against hypoxic “ischemia.”
Assessment of cellular injury. Cellular injury was as-
sessed with the use of nonconfluent cultures of cardiomy-
ocytes and endothelial cells (approximately 337,000 cells
per 9 cm diameter culture dish). After the intervention of
interest, cell plates were incubated with 0.4% trypan blue
dye (Sigma Chemical Company, St. Louis, Mo.), dissolved
in normal saline solution, and assessed for injury under an
inverted light microscope (Nikon Canada Instrument Inc.,
Mississauga, Ontario) at 2003 magnification. Injured cells
were unable to exclude the large molecular weight dye and
stained blue. The number of blue-stained cells was
counted from five standard locations on each plate and
expressed as a percentage of the total number of cells. All
counts were performed by a single, blinded observer.
Biochemical measurements. Confluent cultures of car-
diomyocytes and endothelial cells (approximately 600,000
cells per culture dish) were used for biochemical analysis.
After removal from the culture dish, the cardiomyocytes,
endothelial cells, and the extracellular fluid recovered
from each intervention were analyzed for lactate by means
of an enzymatic method (Stat-Pack rapid lactate test kit,
Behring Diagnostics, La Jolla, Calif.). The concentration
of hydrogen ion [H1] in the extracellular fluid was deter-
mined by converting the pH value measured with a blood
gas analyzer (1312 Blood Gas Manager, Instrumentation
Laboratory, Milan, Italy) to [H1] by the formula: [H1] 5
Antilog (–pH). The DNA in the extract of cells was
recovered in 5% perchloric acid and quantitated with the
use of a spectrophotometric, diphenylamine color reac-
tion with calf thymus DNA as the standard. Hydrogen ion
and lactate values were then corrected for DNA content
from each plate.
Statistical analysis. The SAS program (SAS Institute,
Cary, N.C.) was used for analysis. Results are expressed as
the mean 6 standard error with eight plates per group. A
two-way analysis of variance (ANOVA) was used to test
the main effects: cell type (cardiomyocytes or endothelial
cells), intervention (ischemia and reperfusion), PO2 (0 or
16 mm Hg), and preconditioning (with or without precon-
ditioning) plus their interactive effects. The factorial de-
sign of the study permits a complete statistical evaluation
by a two-way ANOVA without multiple comparisons
between groups. When statistically significant differences
were found, they were specified by a one-way ANOVA
and Duncan’s multiple range test. Statistical significance
was assumed at p , 0.05.
Results
Cell injury assessment. Cellular injury as as-
sessed by trypan blue uptake increased after “isch-
emia” and “reperfusion” (intervention, F 5 188, p ,
0.0001). Reperfusion resulted in further injury to
cardiomyocytes but not endothelial cells
(intervention z cell type, F 5 11, p , 0.0001) using
both anoxic and hypoxic PBS (intervention z cell
type z PO2, F 5 7, p 5 0.002; p , 0.05 for cardio-
myocytes and p . 0.05 for endothelial cells by
Duncan’s multiple range test). Cellular injury was
significantly greater overall for endothelial cells than
cardiomyocytes (cell type, F 5 38, p , 0.0001), but
the difference was significant at a PO2 of 0 mm Hg
and not at a PO2 of 16 mm Hg.
Cellular injury increased in both endothelial cells
and cardiomyocytes as the PO2 fell from hypoxic (16
Fig. 3. Preconditioning effect on anoxic “ischemic” and “reperfusion” injury. Left, Preconditioning
reduced cardiomyocyte cell injury after both ischemia and reperfusion. Right, Preconditioning did not
reduce endothelial cell injury. Abbreviations as detailed in Fig. 1. *p , 0.05 PI versus I and PIR versus IR;
#p , 0.05 IR versus I and PIR versus PI;1p , 0.05 versus cardiomyocytes.
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mm Hg) to anoxic (0 mm Hg) levels (PO2, F 5 54,
p , 0.0001). Reperfusion after hypoxia resulted in
greater injury to cardiomyocytes but not endothelial
cells (intervention z cell type z PO2, F 5 7, p 5
0.0002; p , 0.05 for cardiomyocytes, p . 0.05 for
endothelial cells by Duncan’s multiple range test).
The effects of “ischemia” and “reperfusion” are
summarized in Fig. 2.
Preconditioning. Ischemic preconditioning with
anoxic PBS significantly reduced cell injury (precon-
ditioning, F 5 8, p 5 0.004) in cardiomyocytes but
not endothelial cells (cell type z preconditioning,
F 5 42, p , 0.0001). Preconditioning with anoxic
PBS reduced both ischemic and reperfusion injury
in cardiomyocytes; however, reperfusion augmented
ischemic injury even in preconditioned cells. Neither
preconditioning nor reperfusion had any effect on
endothelial cells (Fig. 3).
An anoxic preconditioning stimulus was more
effective than a hypoxic stimulus (PO2 z precondi-
tioning, F 5 14, p 5 0.0003). Preconditioning with a
hypoxic stimulus was only able to reduce reperfusion
injury in cardiomyocytes. Hypoxic preconditioning
did not affect endothelial cell viability; however,
reperfusion after “hypoxic” ischemia significantly
increased cellular injury. Endothelial cells appear to
be more sensitive to repeated episodes of “isch-
emia” and “reperfusion.” Cellular injury after hy-
poxic and anoxic preconditioning is summarized in
Figs. 3 and 4.
Biochemical measurements. Fig. 5 illustrates ex-
tracellular, intracellular, and total lactate accumula-
tion. During stabilization and normoxic reperfusion,
endothelial cells produced more lactate than cardi-
omyocytes (cell type; F 5 26, p , 0.0001). However,
during anoxic “ischemia” cardiomyocytes increased
lactate production (intervention; F 5 51, p ,
0.0001) to equal that of endothelial cells. Neither
ischemia nor reperfusion increased lactate produc-
tion for the endothelial cells (intervention; F 5 1,
p 5 0.893).
Fig. 6 demonstrates that preconditioning re-
duced intracellular lactate accumulation during
anoxic “ischemia” in cardiomyocytes (F 5 4, p 5
0.058) but not endothelial cells (F 5 1, p 5 0.983).
Endothelial cells had greater intracellular lactate
accumulation than cardiomyocytes (cell type; F 5
26, p , 0.0001).
Fig. 7 demonstrates that preconditioning reduced
extracellular lactate release during anoxic “isch-
emia” in cardiomyocytes (F 5 5, p 5 0.033) but not
endothelial cells (F 5 1, p 5 0.993). Lactate release
was greater in endothelial cells than cardiomyocytes
during normoxic reperfusion.
The extracellular fluid pH fell with anoxic “isch-
emia” in both cell types. The extracellular acid
release was reduced by preconditioning in cardio-
myocytes (intervention z preconditioning; F 5 5,
p 5 0.0298) but not endothelial cells (F 5 0.1, p 5
0.823).
Fig. 4. Preconditioning effect on hypoxic “ischemic” and “reperfusion” injury. Left, Preconditioning
reduced cardiomyocyte injury after reperfusion, but not ischemia. Right, Preconditioning did not reduce
endothelial cell injury and increased cell injury after reperfusion. Abbreviations as detailed in Fig. 1. *p ,
0.05 PIR versus IR; #p , 0.05 IR versus I and PIR versus PI; 1p , 0.05 versus cardiomyocytes.
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Discussion
Human cell cultures. The cardiomyocytes and
endothelial cells used in these studies have been
extensively evaluated in previous reports.15-19 The
endothelial cells isolated from human saphenous
veins retain their histologic characteristics after four
to seven passages. In addition, they retain their
antioxidant enzyme activity and are readily stained
for factor VIII.17 We found that endothelial cells
from different vascular beds become indistinguish-
able after isolation and culture. Thus we believe that
these cells are a useful model of human endothe-
lium but may not reflect the in vivo responses of
coronary endothelium.
The cardiomyocytes retain many similarities to
freshly isolated cells but also have distinct differ-
ences. After enzymatic digestion and passaging, the
cardiomyocytes become quiescent. Other investiga-
tors have reported that adult rat cardiomyocytes
become quiescent once cultured.20, 21 Although the
cardiomyocytes retain an abundant supply of mito-
chondria and contractile proteins, the sarcomeres
become disrupted during division and do not rees-
tablish their characteristic functional format. The
effects of culturing and passaging these cells has
been extensively described in a previous publica-
tion.16 Although the biochemical and molecular
properties of these cells resemble in vivo cardiomy-
ocytes, these cells undergo a partial phenotypic
change, become quiescent, and regain their ability to
divide. Other investigators have shown that senes-
cent rat cardiomyocytes may also regain their ability
to divide in culture.21, 22 Therefore, despite their
quiescent state, we believe that these cells are
phenotypically cardiomyocytes and retain many
characteristics of normal human myocardium and
may simulate the human heart during cardioplegic
arrest. Thus these cells provide a unique opportu-
nity to evaluate the cellular response to “ischemia,”
“reperfusion,” and preconditioning.
Simulated “ischemia” and “reperfusion.” Ex-
posing the cells to 90 minutes of a solution with an
oxygen content of either 0 or 16 mm Hg injured
both cardiomyocytes and the endothelial cells.
Reducing the volume of solution over the cells
from 15 to 1.5 ml resulted in the accumulation of
the products of ischemic metabolism and a
marked reduction in the extracellular pH. There-
fore this model is similar to the effects of global
ischemia on the heart. Unfortunately, the volume
overlying the cells remains greater than the solu-
tion to which the cells are exposed during global
ischemia. Our model differs from simple hypoxia
and reperfusion as a result of the reduction in
supernatant volume. If cells are exposed to 15 ml
of anoxic PBS, the degree of metabolite accumu-
lation and cellular injury is markedly reduced.19
Thus we believe that this model may serve as a
Fig. 5. Extracellular (left), intracellular (center), and total (right) lactate accumulation after ischemia and
reperfusion. Endothelial cells produced more lactate than cardiomyocytes during stabilization and after
reperfusion under normoxic conditions. Cardiomyocytes increased lactate production during ischemia.
Abbreviations as detailed in Fig. 1. 1p , 0.05 versus cardiomyocytes.
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useful tool to investigate the cellular response to
ischemic preconditioning.
Susceptibility to “ischemia.” We found that en-
dothelial cells were more susceptible to simulated
ischemia under both anoxic (PO2 5 0 mm Hg) and
hypoxic (PO2 5 16 mm Hg) conditions. Previous
studies examining endothelial susceptibility to isch-
emia were contradictory.6-9, 23-27 Both histologic and
ultrastructural examination reveal very little endo-
thelial cell injury during global cardiac ischemia or
after reperfusion.1 The lack of histologic abnormal-
ities in endothelial cells despite extensive myocyte
damage led to the conclusion that endothelial cells
were resistant to ischemia. Studies on the effects of
ischemia and reperfusion on endothelial function
have suggested that these cells may be as susceptible
as cardiomyocytes to ischemic injury. Hulsmann and
Dubelaar23 found that endothelial dysfunction was
substantial after brief ischemic episodes. Similarly,
Nakanishi and colleagues6 found severe endothelial
dysfunction after global myocardial ischemia and
reperfusion and a significant impairment of endo-
thelium-dependent coronary vascular relaxation. In
contrast, Tanaka and colleagues24 demonstrated
that cardiomyocytes were more sensitive to ischemia
than cultures of nonmyocytes. These investigators
found DNA fragmentation in neonatal rat cardio-
myocytes exposed to 12 hours of hypoxia, whereas
the nonmyocyte cultures did not display DNA frag-
mentation for up to 72 hours. Unfortunately, these
authors did not characterize the population of their
nonmyocyte cells.
During whole heart ischemia, endothelial cells
may be spared the lowest PO2s because of their
perfusion by collateral circulation. Therefore the
relatively sparse histologic injury may be related to
the lesser degree of hypoxia. In this study we found
that a PO2 of 16 mm Hg was sufficient to significantly
reduce cellular injury compared with anoxic (PO2 5
0 mm Hg) ischemia.
Reperfusion. Most studies have suggested that
endothelial dysfunction occurs during reperfu-
sion.6-9 However, we found that reperfusion did not
increase injury in endothelial cells after either hy-
poxic or anoxic ischemia. In contrast, cardiomyo-
cytes displayed greater injury after reperfusion at
both levels of ischemic insult. Our technique of
assessing cell viability requires 5 minutes of incuba-
tion in trypan blue. It is possible that this brief
period of reperfusion after ischemia was sufficient to
cause reperfusion injury in endothelial cells, which
was not exacerbated with an additional 30 minutes
of reperfusion. After anoxic ischemia and reperfu-
sion, cellular injury was greater in endothelial cells
than in cardiomyocytes. The noncontractile nature
of the cardiomyocytes may have been protective
against ischemia. Energy-consuming contraction
during reperfusion may exacerbate cardiomyocyte
injury to a greater degree than observed in this
study.
Ischemic preconditioning. Ischemic precondi-
tioning was first described by Murry, Jennings, and
Reimer10 in 1986 and may represent the most potent
form of endogenous myocardial protection. Al-
Fig. 6. Preconditioning reduced intracellular lactate accumulation in cardiomyocytes but not endothelial
cells during anoxic ischemia. Endothelial cells accumulated more lactate than cardiomyocytes. Abbrevia-
tions as detailed in Fig. 1. *p , 0.05 PI versus I; 1p , 0.05 versus cardiomyocytes.
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though the effects of preconditioning on cardiomy-
ocyte viability is well established,18, 19 the ability of
endothelial cells to exhibit a preconditioned re-
sponse remains controversial. Defily and Chilian11
reported that ischemic preconditioning preserved
endothelium-dependent coronary vasodilatation
during subsequent prolonged ischemia and reperfu-
sion. They speculated that the preservation of vas-
cular function facilitated myocardial myocyte pres-
ervation. With a similar canine coronary occlusion
model, Bauer and colleagues12 reported the oppo-
site results. They concluded that the effect of isch-
emic preconditioning did not extend to the coronary
vasculature. Endothelial cell viability was not eval-
uated in either study. Most studies on ischemic
preconditioning have demonstrated that cardiomy-
ocyte viability is preserved, but the effects on ven-
tricular function remain controversial.25, 26 There-
fore it is possible that ischemic preconditioning
could affect the metabolic activity of the endothelial
cells without preserving cell viability.
Our previous studies have suggested that cardio-
myocyte preconditioning is mediated by adenosine
receptor stimulation and involves activation of pro-
tein kinase C.18, 19 It is possible that these mecha-
nisms are not active in endothelial cells, which may
explain the lack of a protective effect in response to
a preconditioning stimulus. Adenosine released
from endothelium can be rapidly deaminated.27, 28
Therefore receptor activation could be prevented
despite adenosine release into the culture medium.
Endothelial cells are known to have adenosine A2
receptors, but adenosine A1 and perhaps A3 recep-
tors are required for ischemic preconditioning. The
activity of G proteins, cyclic adenosine monophos-
phate, and adenosine triphosphate–sensitive potas-
sium channels in endothelial cells has not been well
established. Therefore it is possible that the mech-
anisms required for ischemic preconditioning may
not be available in endothelial cells.
We found that a PO2 of 16 mm Hg resulted in mild
injury to both cardiomyocytes and endothelial cells
compared with a PO2 of 0 mm Hg. In addition, we
demonstrated that hypoxia did induce a precondi-
tioning effect in cardiomyocytes, which was not as
potent as that obtained with an anoxic stimulus. If
the release of adenosine contributes to the precon-
ditioning effect, it is possible that hypoxia results in
less adenosine accumulation with a resultant dimi-
nution in the protective response. We were sur-
prised to find that reperfusion after hypoxic precon-
ditioning and ischemia augmented endothelial
injury. This effect may represent the culmination of
three separate insults: a brief period of ischemia,
prolonged ischemia, and reperfusion. In endothelial
cells exposed to anoxic ischemia, we observed ap-
proximately 50% cellular injury. Reperfusion after
hypoxic preconditioning and ischemia also resulted
in 50% cellular injury. Therefore at PO2s of 16 mm
Hg, we observed incremental cell injury after the
preconditioning stimulus, prolonged ischemia, and
reperfusion. At PO2s of 0 mm Hg, 50% cellular
Fig. 7. Preconditioning reduced lactate release into the extracellular fluid in cardiomyocytes during anoxic
ischemia but not in endothelial cells. Endothelial cells produced more lactate than cardiomyocytes during
normoxic reperfusion. Abbreviations as detailed in Fig. 1. *p , 0.05 PI versus I; 1p , 0.05 versus
cardiomyocytes.
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injury was observed after ischemia alone, and reper-
fusion did not result in further injury. It is possible
that cells capable of surviving anoxic ischemia were
resistant to reperfusion injury, whereas cells mildly
injured by hypoxic ischemia suffered augmentation
of their injury after reperfusion. Nakanishi and
associates6 also found that reperfusion was required
to demonstrate endothelial dysfunction after isch-
emia. These authors were unable to demonstrate an
impairment of endothelium-dependent coronary
vascular relaxation after ischemia alone. They used
a canine model with abundant coronary collateral
circulation, which may allow for modest PO2s resem-
bling our hypoxic conditions.
Glycolysis. We demonstrated that endothelial
cells produce more lactate but maintain a normal
pH under normoxic conditions of stabilization or
reperfusion. Mertens and colleagues29 found the
same phenomena in rat coronary endothelial cells.
The amount of lactate produced was greater than
that reported by Spahr and colleagues,30 who stud-
ied cultured rat cardiomyocytes. During 90 minutes
of ischemia, cardiomyocytes increased both intracel-
lular and extracellular lactate. Endothelial cells did
not increase anaerobic glycolysis during prolonged
ischemia. Preconditioning significantly reduced lac-
tate release from cardiomyocytes. Endothelial cell
lactate accumulation was not affected by precondi-
tioning. The suppression of glycolysis by cardiomy-
ocytes has been previously reported in cardiomyo-
cyte cell cultures,18 and this phenomenon has been
reported in vivo by Murry and colleagues.31
In summary, these investigations permit the fol-
lowing conclusions:
1. Endothelial cells were more susceptible to simu-
lated ischemia and reperfusion than cardiomyo-
cytes.
2. Reperfusion increased injury in cardiomyocytes
but not endothelial cells.
3. Ischemic preconditioning reduced cell injury in
cardiomyocytes but not endothelial cells.
4. Ischemic preconditioning diminished lactate pro-
duction in cardiomyocytes but not endothelial
cells.
We believe that attempts to mimic the precondi-
tioning response by pharmacologic additives to car-
dioplegic formulations must address the differential
requirements of both cardiomyocytes and endothe-
lial cells. Furthermore, consideration must be given
to additives that provide beneficial effects on both
viability and function.
We acknowledge the statistical assistance of Ms. Joan
Ivanov, RN, MSc, for her contributions to this manuscript.
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